This Centre was announced by C-CAMP in collaboration with SBI Foundation

WHO has categorized Antimicrobial Resistance as one of global health concerns

Centre will operate within framework of global India AMR Innovation Hub (IAIH)

The establishment of the Centre of Excellence in Antimicrobial Resistance (AMR) innovation in Bengaluru has been announced by the Centre for Cellular and Molecular Platforms (C-CAMP) in collaboration with the SBI Foundation.

The World Health Organization (WHO) has categorized Antimicrobial Resistance as one of the foremost global health concerns, leading to a staggering 700,000 fatalities annually worldwide, with an estimated projection of 10 million deaths yearly by 2050.

C-CAMP highlighted that despite India’s prominence in research for AMR mitigation among the Global South countries, the absence of substantial efforts in translating scientific advancements into practical solutions has been a significant drawback.

Professor Ajay Sood, the Principal Scientific Adviser to the Government of India, emphasized that AMR poses a critical threat to global public health systems, underscoring its priority status at the WHO. He noted the irony of AMR being one of the most underfunded areas in biotechnology, owing to its imbalanced market economics. The collaboration between C-CAMP and SBIF CoE is expected to provide substantial financial and developmental support, thus catalyzing innovation in the field of AMR, as reported by The Hindu.

The newly established centre will operate within the framework of the global India AMR Innovation Hub (IAIH) platform. The center has outlined its initial plan to endorse and foster up to 12 innovative initiatives over the next two years.